BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 2012
View Archived Issues
Ranbaxy Laboratories presents new MMP-9 inhibitors
Read More
Novel anticancer compounds patented by Sanofi
Read More
New BTK inhibitor shows promise to treat B-cell malignancies
Read More
Advinus Therapeutics discloses new adenosine A2A receptor antagonists
Read More
New phase II results on quadruple therapy for treatment-resistant hepatitis C
Read More
Investigators in France rediscover traditional antimalarial agent
Read More
Astellas and Kaketsuken sign Japanese marketing agreement for vaccine
Read More
Novel PI3Kbeta inhibitor shows potential to treat PTEN-deficient tumors
Read More
Alder BioPharmaceuticals raises funds to support development of antibody therapeutics
Read More
CHMP confirms MAA opinion on Folotyn
Read More
Canadian study identifies potential new targets for breast cancer therapy
Read More
Novartis announces changes in fingolimod labeling in U.S. and E.U.
Read More
Array BioPharma discloses new agents for Alzheimer's disease
Read More
Novel products disclosed by Genentech and MRC Technology
Read More
Novel LDL-PLA(2) inhibitors patented by GSK
Read More
BTG reports outcome of second pivotal Varisolve study
Read More
AstraZeneca announces new acquisition plan
Read More
MicuRx completes phase I trial of next-generation oral antibiotic
Read More
Takeda announces CHMP opinion on Rienso
Read More
Japan's MHLW lifts condition on Humira approval
Read More
CHMP issues positive opinion on SkyePharma asthma therapy
Read More
CHMP recommends approval of Jakavi
Read More
European approval of Forxiga recommended
Read More
FDA extends review of linaclotide
Read More
Japan Tobacco and Torii report topline results from phase III GBA4-1 study
Read More
EMA committee maintains recommendation on Glybera
Read More